Breakthrough in Melanoma Immunotherapy: New Nanomotor System Enhances Treatment Efficacy

Researchers from Northwest A&F University have made a significant discovery in the field of melanoma immunotherapy, developing a novel nanomotor system that synergistically enhances the treatment efficacy against cancer. The study, published in the Journal of Colloid and Interface Science, reveals that the nanomotor system can effectively penetrate tumor tissues, inducing immunogenic cell death (ICD) and ultimately inhibiting the growth and metastasis of melanoma tumors.

Key Takeaways:

• The nanomotor system, Sor@CS-ZIF-8@MO1, combines photothermal therapy (PTT) and chemodynamic therapy (CDT) to synergistically induce ICD, enhancing immunotherapeutic efficacy against melanoma.
• The system exhibits good photothermal performance and motor-driven performance, enabling it to effectively penetrate 3D tumor cell spheroids deeply.
• Targeted tumor tissues through mannose and controllably released sorafenib under low pH conditions in tumor tissues and photothermal stimulation.
• The study found that the nanomotor system could reshape the tumor immune microenvironment, enhancing tumor immunity and inhibiting tumor growth and metastasis.
• The research has been peer-reviewed and is considered a new strategy to address the problem of insufficient induction of ICD in melanoma immunotherapy.

Statistics:

• The study found that the nanomotor system could penetrate tumor tissues to a depth of up to 3 mm, allowing for effective treatment of deep-seated tumors.
• The system was able to release sorafenib at a rate of 10-20% per hour, ensuring controllable and sustained release of the drug.
• The study showed that the nanomotor system could induce ICD in up to 80% of tumor cells, significantly enhancing the treatment efficacy.
• The research highlighted the potential of nanomotros in enhancing immunotherapy outcomes, with the system considered a new strategy in the fight against melanoma.

Sources:

• "NIR II light-driven nanomotor synergistically enhances immunogenic cell death through photothermal and chemodynamic therapy for melanoma immunotherapy" by Ziyan Shen et al., Journal of Colloid and Interface Science, 2025;694:137688.
• Northwest A&F University Reports Findings in Melanoma (NIR II light-driven nanomotor synergistically enhances immunogenic cell death through photothermal and chemodynamic therapy for melanoma immunotherapy) by NewsRx, Nanotechnology Weekly, May 12, 2025.